Genworth Financial is expected to report Q2 2026 revenue of $1.70 billion and earnings of $0.28 per share, with the stock currently trading at $9.83 against a $12.00 analyst price target.
Investors are primarily focused on the execution of the company's $195 million to $225 million full-year share repurchase target.
This buyback program is fueled by capital returns from majority-owned subsidiary Enact Holdings, which remains the core driver of Genworth's adjusted operating income. Additionally, the market is assessing the impact of CEO Tom McInerney’s recent leave of absence and the ongoing progress of premium rate increases in the long-term care segment.